U.S. Antisense And Rnai Therapeutics Market Size & Outlook

Name: U.S. Antisense And Rnai Therapeutics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The antisense and rnai therapeutics market in the United States is expected to reach a projected revenue of US$ 9,222.7 million by 2030. A compound annual growth rate of 19.1% is expected of the United States antisense and rnai therapeutics market from 2024 to 2030.

Biotechnology
- RNA analysis
  - Antisense And RNAi Therapeutics Market Outlook

U.S. antisense and rnai therapeutics technology outlook (Revenue, USD million, 2018-2030)
- RNA Interference
- Antisense RNA
U.S. antisense and rnai therapeutics application outlook (Revenue, USD million, 2018-2030)
- Neurodegenerative Disorders
- Genetic Disorders
- Cardiometabolic & Renal Disorders
- Ocular
- Cancer
- Skin Diseases
- Infectious Diseases
U.S. antisense and rnai therapeutics route of administration outlook (Revenue, USD million, 2018-2030)
- Intravenous Injections
- Intrathecal Injections
- Subcutaneous Injections
- Other Delivery Methods

U.S. Antisense And Rnai Therapeutics Market Size & Outlook

Data Tree

Sign up - it's easy, and free!